Thu. Mar 13th, 2025
Lab-Grown Diamond Co. Adamas One Risks Nasdaq Delisting
Scottsdale, Ariz.—Lab-grown diamond agency Adamas One Corp. is liable to being delisted from the Nasdaq stock alternate after failing to file its Form 10-Okay.

The form is an annual report required by the U.S. Securities and Change Charge that gives a top level view of a publicly traded agency’s financial effectivity.

The company launched in a press launch that it has acquired a letter from Nasdaq’s Itemizing {{Qualifications}} Division after it did not file a Form 10-Okay for its fiscal yr ended Sept. 30.

The lab-grown diamond producer is headquartered in Scottsdale, Arizona, and has companies in Greenville, South Carolina.

The company holds 36 patents, using a proprietary chemical vapor deposition course of to develop diamond crystals.

It trades beneath the ticker picture JEWL and its stock remaining closed at about $0.60 per share.

 Related tales will possible be correct proper right here … 

If the company would not regain compliance in a nicely timed technique, its widespread stock will possible be subject to delisting from Nasdaq.

Adamas One has until March 19 to file the report or submit a plan to Nasdaq to be once more in compliance, in accordance with the discharge.

If Nasdaq accepts the plan, Adamas One has as a lot as 180 days from the due date for submitting to regain compliance.

If the plan should not be accepted, the company should attraction that decision to a Nasdaq Hearings Panel.

Inside the launch, Adamas One mentioned, “The company is working diligently and expects to file its Annual Report 2023 Form 10-Okay shortly, which could eradicate the need for the company to submit a correct plan to regain compliance.”

The company launched plans in August to build up India-based lab-grown diamond producer Flawless Appeal to Grown Diamonds LLP.  

Adamas One did not reply to a request for an change on the acquisition.

By

Leave a Reply

Your email address will not be published. Required fields are marked *